› Acesso aberto
Anand U, et al. Cannabinoid receptor CB2 localisation and agonist−mediated inhibition of capsaicin responses in human sensory neurons. Pain. 2008; 138, 667−80.
→ Link de acesso
› Acesso aberto
Baswan SM, et al. Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. Clin Cosmet Investig Dermatol. 2020; 13:927-942.
→ Link de acesso
› Acesso aberto
Biro T, et al. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci. 2009; 30, 411−20.
→ Link de acesso
› Acesso aberto
Caterina MJ. TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation. ACS Chem Neurosci. 2014; 5(11):1107−16.
→ Link de acesso
› Acesso pago
Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov. 2008; 7(5):438−55.
→ Link de acesso
› Acesso aberto
Few J, et al. A Single-Center Study Evaluating the Effects of a Novel Retinol and Cannabidiol Combination Topical on Facial Skin. Aesthet Surg J Open Forum. 2022; 4
→ Link de acesso
› Acesso pago
Friedman AJ, et al. Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature. J Drugs Dermatol. 2020; 19(8):795.
→ Link de acesso
› Acesso pago
Gupta AK, Talukder M. Cannabinoids for skin diseases and hair regrowth. J Cosmet Dermatol. 2021 20(9):2703-2711.
→ Link de acesso
› Acesso aberto
Hammell DC, et al. Transdermal cannabidiol reduces inflammation and pain−related behaviours in a rat model of arthritis. Eur J Pain. 2016; 20(6): 936−948.
→ Link de acesso
› Acesso pago
Junaid MSA, et al. In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils. Int J Pharm 2022; 616
→ Link de acesso
› Acesso aberto
Kupczyk P, et al. Cannabinoid system in the skin − a possible target for future therapies in dermatology. Exp Dermatol. 2009;18(8):669−79.
→ Link de acesso
› Acesso aberto
Laborada J, Cohen PR. Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology. Cureus. 2022;14(4)
→ Link de acesso
› Acesso pago
Lodzki M, et al. Cannabidiol−transdermal delivery and anti−inflammatory
effect in a murine model. J. Control. Release. 2003; 93:377−87.
→ Link de acesso
› Acesso pago
Maghfour J, et al. An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin. J Drugs Dermatol. 2020; 19(12):1204-1208.
→ Link de acesso
› Acesso pago
Maghfour J, et al. Tolerability Profile of Topical Cannabidiol and Palmitoylethanolamide: A Compilation of Single-Center Randomized Evaluator-Blinded Clinical and In Vitro Studies in Normal Skin. Clin Exp Dermatol. 2021
→ Link de acesso
› Acesso aberto
Maida V e Corban J. Topical Medical Cannabis: A New Treatment for Wound Pain – Three Cases of Pyoderma Gangrenosum. J Pain Symptom Manage. 2017;54(5):732−6.
→ Link de acesso
› Acesso aberto
láh A, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest. 2014 ;124(9):3713−24.
→ Link de acesso
› Acesso pago
Oláh A, et al. Differential effectiveness of selected non−psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Exp Dermatol. 2016 Sep;25(9):701−7.
→ Link de acesso
› Acesso aberto
Palmieri B , et al. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clin Ter. 2019; 170(2):e93-e99.
→ Link de acesso
› Acesso aberto
Rietcheck HR, et al. Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson’s Disease and the Potential Role of Oral Cannabinoids. Dermatology. 2020.
→ Link de acesso
› Acesso pago
Río CD, et al. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. Biochem Pharmacol. 2018; 157:122−33.
→ Link de acesso
› Acesso aberto
Scheffer IE, et al. Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial. JAMA Netw Open. 2021; 4(9)
→ Link de acesso
› Acesso aberto
Sivesind TE, et al. Cannabinoids for the Treatment of Dermatologic Conditions. JID Innov. 2022; 2(2)
→ Link de acesso
› Acesso pago
Stander S, et al. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci.2005; 38, 177−88.
→ Link de acesso
› Acesso aberto
Szachowicz-Petelska B, et al. The Differential Effect of Cannabidiol on the Composition and Physicochemical Properties of Keratinocyte and Fibroblast Membranes from Psoriatic Patients and Healthy People. Membranes (Basel). 2021; 4;11(2):111.
→ Link de acesso
› Acesso pago
Van Zuuren EJ. Rosacea. N Engl J Med. 2017; 377(18):1754−64.
→ Link de acesso
› Acesso aberto
Zouboulis CC, et al. What is the pathogenesis of acne? Exp Dermatol. 2005; 14(2):143−52.
→ Link de acesso
